Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Chularat Hospital PCLBKK:CHG-R 81 Future 3-5Y EPS without NRI Growth Rate is 4.17 as of Sep. 01, 2026. GuruFocus rates BKK:CHG-R with a GF Score™ of 81/100 and a GF Value™ of ฿1.97 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 199 Healthcare Providers & Services companies, Chularat Hospital PCL ranks worse than 96.98% on this metric.
Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.
As of today, Chularat Hospital PCL's Future 3-5Y EPS without NRI Growth Rate is 4.17.
Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.
Chularat Hospital PCL Future 3-5Y EPS without NRI Growth Rate Related Terms
BKK:CHG-R vs HCA, THC, EHC: Future 3-5Y EPS without NRI Growth Rate Comparison
For the Medical Care Facilities subindustry, Chularat Hospital PCL's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chularat Hospital PCL Future 3-5Y EPS without NRI Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Chularat Hospital PCL's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Chularat Hospital PCL's Future 3-5Y EPS without NRI Growth Rate falls into.
What does a Future 3-5Y EPS without NRI Growth Rate of 4.17 mean?
Chularat Hospital PCL (BKK:CHG-R) has a Future 3-5Y EPS without NRI Growth Rate of 4.17 as of Sep. 01, 2026. EPS Growth Rate (Future 3Y To 5Y Estimate) is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period. View historical data for Chularat Hospital PCL and its competitors. According to the industry distribution chart, Chularat Hospital PCL ranks #193 out of 199 companies in the Healthcare Providers & Services industry, placing it in the top 97%.
Is Chularat Hospital PCL's Future 3-5Y EPS without NRI Growth Rate too high?
Chularat Hospital PCL's current Future 3-5Y EPS without NRI Growth Rate is 4.17. The Healthcare Providers & Services industry median Future 3-5Y EPS without NRI Growth Rate is 17.85. Chularat Hospital PCL's value of 4.17 is 76.6% below this industry median. Based on the distribution chart, Chularat Hospital PCL ranks #193 out of 199 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Chularat Hospital PCL has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Chularat Hospital PCL's Future 3-5Y EPS without NRI Growth Rate compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Chularat Hospital PCL ranks #193 out of 199 companies for Future 3-5Y EPS without NRI Growth Rate. This places Chularat Hospital PCL in the lower half of its industry. The industry median Future 3-5Y EPS without NRI Growth Rate is 17.85. Chularat Hospital PCL's value of 4.17 is 76.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Future 3-5Y EPS without NRI Growth Rate for a Healthcare Providers & Services company?
The median Future 3-5Y EPS without NRI Growth Rate among Healthcare Providers & Services companies is 17.85, based on 199 companies in the industry. Companies in the top quartile (top 25%) have a Future 3-5Y EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, Future 3-5Y EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chularat Hospital PCL's current Future 3-5Y EPS without NRI Growth Rate of 4.17 is 76.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Future 3-5Y EPS without NRI Growth Rate mean?
A high Future 3-5Y EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. EPS Growth Rate (Future 3Y To 5Y Estimate) is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period. View historical data for Chularat Hospital PCL and its competitors. For the Healthcare Providers & Services industry, the median Future 3-5Y EPS without NRI Growth Rate is 17.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chularat Hospital PCL's current Future 3-5Y EPS without NRI Growth Rate is 4.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chularat Hospital PCL stock overvalued right now?
Based on GuruFocus' analysis, Chularat Hospital PCL (BKK:CHG-R) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿1.97, compared to a current price of ฿1.56 — trading 20.8% below its estimated fair value. The current Future 3-5Y EPS without NRI Growth Rate is 4.17 and 76.6% below the Healthcare Providers & Services industry median of 17.85. Chularat Hospital PCL's overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Future 3-5Y EPS without NRI Growth Rate calculated?
Future 3-5Y EPS without NRI Growth Rate is calculated from a company's financial statements. For Chularat Hospital PCL (BKK:CHG-R), the current Future 3-5Y EPS without NRI Growth Rate is 4.17 as of Sep. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chularat Hospital PCL (BKK:CHG-R) Overvalued in 2026?
Based on GuruFocus' analysis, Chularat Hospital PCL stock appears to be undervalued.
The current stock price of ฿1.56 is trading 20.8% below its estimated GF Value™ of ฿1.97.
GuruFocus considers Chularat Hospital PCL to be Modestly Undervalued.
Key valuation signals for BKK:CHG-R:
Future 3-5Y EPS without NRI Growth Rate: 4.17
GF Value™: ฿1.97 vs. price of ฿1.56 (20.8% below fair value)
Industry Position: 76.6% below the Healthcare Providers & Services median (#193 of 199)
No single metric tells the full story. See the BKK:CHG-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chularat Hospital PCL operates hospitals and clinics in Thailand. The company operates through several branches of clinics and hospitals. The Group operates a private hospital business which is one business segment. It has only one geographical segment as the business operates only in Thailand.
81GF Score
Get the complete analysis for BKK:CHG-R
Future 3-5Y EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:CHG-R has been successfully added to your 
